In cancer cells, PTK6 promotes oncogenic signaling at the membrane and in the cytoplasm through interactions with growth factor receptors and cytoplasmic substrates such as IRS4, paxillin, STATs, (reviewed in [1], [22]), and AKT [40]. Here, AKT1 is linked to cancer.